Navigation Links
Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies
Date:7/20/2011

LAS VEGAS, July 20, 2011 /PRNewswire/ -- Cardinal Health today announced that this week's Retail Business Conference (RBC), its annual, national trade show for independent pharmacies, is the largest in the event's 20+ year history, with nearly 7,000 attendees.

This year's event, taking place July 20-23 in Las Vegas and held at The Palazzo resort hotel, features a 100,000-square-foot trade show floor, highlighting buying opportunities with more than 330 exhibitors. At the event, pharmacists can access more than 50 continuing education courses on topics that can help them improve both their clinical and business operations. They can also access seven, full- or half-day continuing pharmacy education courses, on issues ranging from pharmacy-based immunization delivery to helping patients manage cardiovascular risk.

"We believe this is one of the largest gatherings of retail independent pharmacies in one place, ever," said Steve Lawrence, senior vice president of retail independent sales for Cardinal Health. "RBC is an outstanding opportunity for independent pharmacy owners to network with peers from across the country, tap into more continuing education courses than they'll find anywhere else, and learn about the many ways Cardinal Health can help them improve the efficiency and profitability of their businesses."

Because many community pharmacists bring their families to the show, the event also features "Camp Cardinal Health," which provides children of all ages with four days of age-appropriate, on-and-off site entertainment opportunities and special events.

The company will also highlight its broad array of solutions that help community pharmacies diversify revenue, improve reimbursements, expand marketshare and improve their overall business operations. New services highlighted at this year's RBC include:

  • Enhancements to Cardinal Health's Front-End Product Management solution,
    '/>"/>

SOURCE Cardinal Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
2. Drug-Related Poisoning The Cause For Nearly 700,000 Emergency Department Visits a Year, According to New Research
3. Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents
4. Ohio Business, Health Care Leaders Collaboration to Improve Patient Safety Results in Estimated Annual Savings of Nearly $13 Million
5. The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments
6. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
7. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
8. In First- and Second-Line Treatment of Clostridium Difficile Infection, Nearly 70 Percent of Surveyed Infectious Disease Specialists and Internists Will Use Fidaxomicin and Nearly Half Will Use CDA1/CDB1
9. Southwest Hospitals MRI Centers Commitment to State-of-the-Art Technology at the Heart of Nearly 20-Year Relationship with MedInformatix RIS
10. Heart Device Manufacturer in Minnesota and Hospitals in Ohio & Kentucky to Pay Nearly $4 Million to Resolve Fraud Allegations
11. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... MONMOUTH JUNCTION, N.J. , Dec. 22, 2014 ... immunotherapy company marketing its CytoSorb® blood purification technology ... cardiac surgery patients in 28 countries worldwide, today ... Di Russo , MD, FACS, as its Senior ... 2015. Dr. Di Russo ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... addition of the "US Self-monitoring Blood Glucose Market" ... http://photos.prnewswire.com/prnh/20130307/600769 This market insight focuses ... in the United States . Reimbursement ... studied. Thorough product analyses for more than 73 SMBG ...
(Date:12/22/2014)... 22, 2014  ConvaTec, a privately-held medical products and ... appointed Interim Chief Executive Officer of the company, effective ... Ken Berger .  "The Board of Directors of ConvaTec ... over the past three years," said Magnus Lundberg ... are confident that the company is well positioned for ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... Health Canada to open clinical sites ... Institute, PHILLIPSBURG, N.J., Dec. 7 Celldex ... Administration (FDA) has,granted orphan drug designation for Celldex,s ... (GBM). GBM is the most common,and aggressive form ...
... ... ... EST Q It,s an interesting time, so we really are eager to talk to you about,especially ... I,d love your overall assessment from -- of what,s,been happening on the Hill, like Pelosi,s leadership and ...
Cached Medicine Technology:Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 2Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 3Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 4Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme 5Interview of the Vice President 2Interview of the Vice President 3Interview of the Vice President 4Interview of the Vice President 5Interview of the Vice President 6Interview of the Vice President 7Interview of the Vice President 8Interview of the Vice President 9Interview of the Vice President 10Interview of the Vice President 11Interview of the Vice President 12Interview of the Vice President 13Interview of the Vice President 14Interview of the Vice President 15Interview of the Vice President 16
(Date:12/25/2014)... “Every three months the trends for evening dresses ... be one of the hottest styles in the next few ... company releases 26 A-line sweetheart evening dresses, and announces the ... “We are trying our best to help a lady to ... with affordable prices, we provide discounted delivery costs to our ...
(Date:12/25/2014)... Angeles, CA (PRWEB) December 25, 2014 The ... Dolcemaschio was created in honor of a true 9/11 ... at two film festivals including the 24 hours of Nuremberg ... Festival in Bangladesh. , Actress, screenwriter and director ... helped produce this film together with her husband, Gregory ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... chronic illnesses can receive effective, less expensive care from a ... to a team of dedicated health care professionals, a new ... ill and need either hospitalization or a trip to the ... home clinic at the University of Texas in Houston versus ...
(Date:12/25/2014)... (HealthDay News) -- Among early stage breast cancer patients ... of one percent will eventually develop leukemia as a ... The finding comes from a review of more than ... and it suggests that the risk for developing treatment-related ... previously thought. "The frequency of bone marrow cancers ...
Breaking Medicine News(10 mins):Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... technology developed at the University at Buffalo has killed ... including airborne spores, viruses and bacteria in independent tests ... A prototype produced by Buffalo BioBlower Technologies LLC, a ... of better than one part per million in an ...
... Removal of Toxic Mercury,from Vaccines, NIXA, Mo., ... (ACIP) recommended yesterday that flu shots be,administered annually ... age. ACIP,functioning under the Centers for Disease Control ... by parents of vaccine-injured,children for neglecting vaccine safety ...
... PAULO, Brazil, Feb. 28 Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the ... Quarter 2007 Earnings Conference Call, When: Thursday, March ... , How: Live over the Internet -- ... address above., Conference call dial-in phone ...
... European Commission Director General for Enterprise & Industry Heinz Zourek ... of an EC budget of 624 million to ESA as ... (GSC). , This will be provided in two stages: 419 ... of the GSC programme. Segment 2 will be submitted for ...
... Allscripts-Led Initiative Works With Google Health to Enable ... Collaboration between ... Direct from the 2008,HIMSS Exhibition and Conference, ... information solutions that physicians,use to improve healthcare, announced ...
... North Carolina State University have found that humans and ... also share the same genetic basis for certain types ... of the way the genomes have evolved, getting cancer ... Jaime Modiano, V.M.D., Ph.D., University of Minnesota College of ...
Cached Medicine News:Health News:UB's bioblower closer to protecting soldiers from biological attack 2Health News:UB's bioblower closer to protecting soldiers from biological attack 3Health News:CDC Vaccine Committee Recommends More Shots for Children 2Health News:Space sentinels: New 'tools' in space to improve European environment and security policies 2Health News:Space sentinels: New 'tools' in space to improve European environment and security policies 3Health News:The National ePrescribing Patient Safety Initiative Collaborates With Google 2Health News:The National ePrescribing Patient Safety Initiative Collaborates With Google 3Health News:The National ePrescribing Patient Safety Initiative Collaborates With Google 4Health News:U of Minn researchers discover genetic cancer link between humans and dogs 2Health News:U of Minn researchers discover genetic cancer link between humans and dogs 3
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease...
Human Growth Hormone EIA Endocrine Function 025-BC-1033...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
Intact PTH EIA Bone and Mineral Metabolism 021-SDX016 Parathyroid Hormone...
Medicine Products: